Richard J. Rodgers - 29 Oct 2022 Form 4 Insider Report for NOVAVAX INC (NVAX)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NVAX	Stock Option (Right to buy)	Award	$0	+17,095		$0.000000	17,095	29 Oct 2022	Common Stock	17,095	$23.02	Direct	F1
transaction	NVAX	Restricted Stock Units	Award	$0	+11,400		$0.000000	11,400	29 Oct 2022	Common Stock	11,400		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The shares subject to this option grant under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), will vest with respect to one-third (1/3) of the shares on each of the first three (3) anniversaries of the October 29, 2022 grant date (the "Grant Date"), in each case subject to continued service on the Company's Board of Directors through such vesting date.
F2	Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock.
F3	The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued service on the Company's Board of Directors through such vesting date.